The mobile health market will grow eightfold over the course of the next decade, from $5.1 billion in 2013 to $41.8 billion in 2023, according to a recent report from Lux Research. The firm defines mobile health technology as leveraging "common consumer electronics and mobile communication technologies to collect and analyze personal health data". The decade of impressive growth will be driven by...
Remote patient monitoring company HealthInterlink received FDA 510(k) class II clearance for Beacon 2.0, a mobile-centric software system that integrates data from various home health devices. Beacon was previously cleared as a class I medical device (MDDS). HealthInterlink plans to begin commercialization of the device in the US immediately.
Beacon 2.0 works on tablets, smartphones and via...
By Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green
My wife complains I live in the future, and I suppose that’s true. But on the heels of three days of hearings last week by two subcommittees of the House Energy and Commerce Committee, all focused on mHealth, I feel the urge to plan for the regulatory world after FDA publishes its final guidance. FDA testified the...
NovaSom, maker of home tests for obstructive sleep apnea, has its first provider partnership for its AccuSom Deliver out-of-center sleep testing program, and it's a big one. The Glen Burnie, Md.-based vendor announced Wednesday that it will offer the service through the SSM Center for Sleep Disorders, part of major Catholic integrated delivery network SSM Health Care – St. Louis.
The seven SSM...
Asthmapolis announced today that the US Food and Drug Administration (FDA) has granted its asthma sensor and companion software 510(k) clearance. The company's device is a sensor that sits atop (most) inhalers used by patients who have asthma or COPD. The sensor transmits data to a companion app on the user's mobile phone every time the inhaler is used. The app can then track the time and...
iSonea's Wheezometer
Annapolis, Maryland-based asthma monitoring technology company iSonea has inked a deal with Qualcomm Life, a subsidiary of Qualcomm, to combine iSonea's proprietary Acoustic Respiratory Monitoring (ARM) devices and forthcoming mobile health asthma management offerings with Qualcomm's recently launched 2net platform.
The deal will enable users of iSonea's asthma monitoring...
